TW EN

scroll

Go Top

Overview

TCTC

In Taiwan, the reimbursement for chemotherapy drugs to treat head and neck cancer, or esophageal cancer is very limited. Therefore, most of the oncologists and surgical oncologists treated patients by jointing the international clinical trials or PI initiated clinical trial. Our previous experience in clinical trials demonstrated we were well qualified and received recognition by international pharmaceutical company. To facilitate performing good quality clinical trials in Taiwan, we plan to establish Head and neck cancer and esophageal cancer consortium.

Strengths

TCTC

1. Head and neck cancer
2. Esophageal cancer

Major Achievements

TCTC

1. To organize and establish the Taiwan Head and Neck cancer and Esophageal cancer consortium group to collect clinical data and tissue specimen.

2. To help domestic company to perform clinical trial for generic drugs.

3. To facilitate PI initiated clinical trials

4. To help domestic company develop novel drugs and translation to clinical trials.

5. To join more international clinical trials and complete the trials in time in this consortium.

Members

TCTC

Department of Oncology, Taipei Veterans General Hospital

Department of Oncology, Taipei Veterans General Hospital

Department of Oncology, Taipei Veterans General Hospital

Department of Oncology, Taipei Veterans General Hospital

Department of Oncology, Taipei Veterans General Hospital

Department of Oncology, Taipei Veterans General Hospital

Division of Hematology & Oncology, China Medical University Hospital

Division of Hematology & Oncology, China Medical University Hospital

Division of Hematology & Oncology, China Medical University Hospital

Department of Oncology, National Chung Kung University Hospital

Division of Gastroenterology, Kaohsiung Medical University Hospital

Division of Hematology & Oncology, Kaohsiung Medical University Hospital

Contact Information

c-IRB

Muh-Hwa Yang

Email:mhyang2@vghtpe.gov.tw

TEL:2875-7270 ext